Cryoablation for the Treatment of Patients with Prostate Bed Tumor Recurrence

This clinical trial tests the Galil magnetic resonance (MR)-compatible cryoablation system for the treatment of patients with prostate bed tumor which has come back after a period of improvement (recurrence). The traditional standard therapy for prostate cancer with intent for cure has been either surgical resection or radiotherapy; however, a significant number of men develop recurrent cancer each year. There are several treatments available to treat recurrence, including cryoablation. Cryoablation, also known as cryosurgery or cryotherapy, kills tumor cells by freezing them. The purpose of this research is to see if MR-guided cryoablation using the Galil MR-compatible cryoablation system can effectively treat prostate tumor recurrences.

Additional locations may be listed on ClinicalTrials.gov for NCT01727284.

See trial information on ClinicalTrials.gov for a list of participating sites.

Trial PhaseNo phase specified

Trial Typetreatment

Lead OrganizationMayo Clinic in Rochester

Principal InvestigatorDavid A. Woodrum

• Primary ID12-002245
• Secondary IDsNCI-2023-01699
• ClinicalTrials.gov IDNCT01727284